Diabetic nephropathy future or investigational therapies
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aarti Narayan, M.B.B.S [2]
Overview
Future or Investigational Therapies
C-peptide, a by-product of insulin production, may provide new hope for patients sufering from diabetic nephropathy [1] [2].
References
- ↑ C-peptide is a bioactive peptide. [Diabetologia. 2007] – PubMed Result
- ↑ Wahren J, Ekberg K, Jörnvall H (2007). “C-peptide is a bioactive peptide”. Diabetologia. 50 (3): 503–9. doi:10.1007/s00125-006-0559-y. PMID 17235526.
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH